These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 186621)

  • 1. Transformation of tonsil lymphocytes by Epstein-Barr virus.
    Yamamoto N; Katsuki T; Hinuma Y
    J Natl Cancer Inst; 1976 Jun; 56(6):1105-7. PubMed ID: 186621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of Epstein-Barr virus-carrying lymphoblastoid cells derived from human tonsil: EBV production and autoantibody response.
    Takimoto T; Tanaka S; Ishikawa S; Masuda K; Umeda R
    ORL J Otorhinolaryngol Relat Spec; 1989; 51(5):257-61. PubMed ID: 2554232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [In vitro immunization of human lymphocytes with Epstein-Barr virus capsid antigen].
    Kulikov VV; Krivonos AV; Krasheninnikov ME; Borisova OV; Kal'nov SL
    Biull Eksp Biol Med; 1991 Jan; 111(1):62-4. PubMed ID: 1647234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Epstein-Barr virus (EBV)-determined nuclear antigen (EBNA5) partly encoded by the transformation-associated Bam WYH region of EBV DNA: preferential expression in lymphoblastoid cell lines.
    Dillner J; Kallin B; Alexander H; Ernberg I; Uno M; Ono Y; Klein G; Lerner RA
    Proc Natl Acad Sci U S A; 1986 Sep; 83(17):6641-5. PubMed ID: 3018741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary CD4+ T-cell responses provide both helper and cytotoxic functions during Epstein-Barr virus infection and transformation of fetal cord blood B cells.
    MacArthur GJ; Wilson AD; Birchall MA; Morgan AJ
    J Virol; 2007 May; 81(9):4766-75. PubMed ID: 17314172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunological role of human palatine tonsil in Epstein-Barr virus persistence.
    Hirao M; Harabuchi Y; Kataura A; Imai S; Osato T
    Acta Otolaryngol Suppl; 1996; 523():158-60. PubMed ID: 9082768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr nuclear antigen (EBNA) carrying lymphocytes in human palatine tonsils.
    Veltri RW; McClung JE; Sprinkle PM
    J Gen Virol; 1976 Sep; 32(3):455-60. PubMed ID: 184241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Viral infections associated with recurrent tonsillitis.
    Yamanaka N; Kataura A
    Acta Otolaryngol Suppl; 1984; 416():30-7. PubMed ID: 6099955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simple assay method for susceptibility of human lymphocytes to Epstein-Barr virus infection.
    Takada K; Osato T
    Intervirology; 1982; 18(1-2):87-91. PubMed ID: 6288618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between Epstein-Barr virus seroconversion and immunohistochemical changes in tonsils of pediatric solid organ transplant recipients.
    Shapiro NL; Tang CG; Bhattacharyya N
    Laryngoscope; 2011 Aug; 121(8):1718-25. PubMed ID: 21792960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tonsillar CD56brightNKG2A+ NK cells restrict primary Epstein-Barr virus infection in B cells via IFN-γ.
    Jud A; Kotur M; Berger C; Gysin C; Nadal D; Lünemann A
    Oncotarget; 2017 Jan; 8(4):6130-6141. PubMed ID: 28008151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spontaneous lymphoblastoid transformation of cells obtained from human tonsils.
    Takimoto T; Tanaka S; Masuda K; Umeda R
    ORL J Otorhinolaryngol Relat Spec; 1989; 51(2):77-82. PubMed ID: 2540474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survey of nonhuman primates for antibodies reactive with Epstein-Barr virus (EBV) antigens and susceptibility of their lymphocytes for immortalization with EBV.
    Ishida T; Yamamoto K
    J Med Primatol; 1987; 16(6):359-71. PubMed ID: 2828628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Four virally determined nuclear antigens are expressed in Epstein-Barr virus-transformed cells.
    Kallin B; Dillner J; Ernberg I; Ehlin-Henriksson B; Rosén A; Henle W; Henle G; Klein G
    Proc Natl Acad Sci U S A; 1986 Mar; 83(5):1499-503. PubMed ID: 3485288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Appearance of Epstein-Barr virus nuclear antigen in human cordblood lymphocytes.
    Wright J; Falk L; Deinhardt F
    IARC Sci Publ (1971); 1975; (11 Pt 1):409-14. PubMed ID: 190146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functionally active Epstein-Barr virus-transformed follicular dendritic cell-like cell lines.
    Lindhout E; Lakeman A; Mevissen ML; de Groot C
    J Exp Med; 1994 Apr; 179(4):1173-84. PubMed ID: 8145036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoglobulin production by tonsil lymphocytes before and after Epstein-Barr virus transformation.
    Speirs JI; Konowalchuk J; Perelmutter L
    Cell Immunol; 1982 Nov; 74(1):64-71. PubMed ID: 6297809
    [No Abstract]   [Full Text] [Related]  

  • 18. Development of cell systems to study viral gene transcription at the initial phase of Epstein-Barr virus infection.
    Harada H; Sawada K; Kudo S; Smith M; Jessip J; Tanaka A; Nonoyama M
    Virus Genes; 1987 Nov; 1(1):73-82. PubMed ID: 2854323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of Epstein-Barr virus infection models in a series of pediatric carriers from a developing country.
    Vistarop AG; Cohen M; De Matteo E; Preciado MV; Chabay PA
    Sci Rep; 2016 Mar; 6():23303. PubMed ID: 26988293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody-dependent autologous lymphocyte cytotoxicity against cells freshly transformed by Epstein-Barr virus.
    Aya T; Matsuo T; Takada K; Osato T; Mizuno F
    IARC Sci Publ (1971); 1978; (24 Pt 2):711-9. PubMed ID: 221393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.